Optimization of an Experimental Vaccine To Prevent Escherichia
Descrição
Frontiers Optimizing Spatio-Temporal Allocation of the COVID-19 Vaccine Under Different Epidemiological Landscapes
Frontiers Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli
In silico design, production and immunization evaluation of a recombinant bivalent fusion protein candidate vaccine against E. coli O157:H7 - ScienceDirect
Media optimization for SHuffle T7 Escherichia coli expressing SUMO-Lispro proinsulin by response surface methodology, BMC Biotechnology
Research implementation and evaluation of the maternity waiting home program for enhancing maternal health in remote area of Indonesia - Clinical Epidemiology and Global Health
Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis
Vaccines, Free Full-Text
Microorganisms, Free Full-Text
Frontiers Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs: Trends in Pharmacological Sciences
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Current view on novel vaccine technologies to combat human infectious diseases
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/cdn.vox-cdn.com/uploads/chorus_asset/file/23453261/apex_legends_mobile_a.jpg)
